Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- SpringWorks Therapeutics, Inc.
Updated Jul 16, 2026
ALBAN CARLOS has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-01 | SOLV | Solventum Corp | M — Option exercise | 3.4K | $0.00 | |
| 2026-03-30 | SOLV | Solventum Corp | M — Option exercise | 2.0K | $0.00 | |
| 2025-07-01 | SWTX | SpringWorks Therapeutics, Inc. | D — Derivative transaction | 28.9K | — |
ALBAN CARLOS is a corporate insider — currently tracked as Director of Solventum Corp (SOLV). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ALBAN CARLOS profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.